Flexible Stent Treats Iliofemoral Venous Occlusive Disease
By HospiMedica International staff writers Posted on 25 Mar 2019 |
Image: The Venovo stent is specifically designed for arteries (Photo courtesy of BD).
A novel stent treats iliofemoral venous occlusive disease (IVOD), the obstruction or narrowing of blood flow specific to the iliac and femoral veins, located near the groin.
The BD (Franklin Lakes, NJ, USA) Venovo venous stent is specifically designed to reopen blocked iliac and femoral veins in order to maintain adequate blood flow in symptomatic IVOD post-thrombotic and non-thrombotic lesions. The flexible nitinol stent maintains a balance of radial strength, compression resistance, and flexibility specifically designed to meet the demands of veins, as opposed to arteries. For example, the ends are flared to enhance vein-wall apposition, and broad stent sizing allows clinicians to treat large diameter veins (10-20 mm) and long lesion lengths (from 40 mm to 160 mm). Six radiopaque tantalum markers aid in positioning.
A prospective, multicenter, single-arm trial involving 170 patients showed a weighted primary patency rate of 88.3%, with a 96.9% patency rate in non-thrombotic lesions and an 81.3% patency rate in post-thrombotic lesions at 12 months, exceeding the performance goal of 74%. In addition, patients treated with the Venovo reported a significant reduction in pain symptoms and improvement in quality of life at 12 months from baseline. The Venovo venous stent was also deployed successfully to the target lesion and showed adequate coverage in all cases, and there were no fractures seen at 12 months.
“The Venovo venous stent represents a significant advance for interventionalists treating iliofemoral venous occlusive disease, an under recognized condition,” said Steve Williamson, worldwide president of peripheral intervention at BD. "We designed the Venovo venous stent in collaboration with clinicians to enable them to treat both post-thrombotic and non-thrombotic lesions. Clinicians will now have access to the broadest range of stent sizes in the United States for these difficult-to-treat lesions.”
“The unique attributes of the Venovo stent make it particularly well-suited to treat iliofemoral occlusive disease,” said Michael Dake, MD, of the University of Arizona, the principal investigator for the Venovo U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) trial. “Most importantly, it is purpose-built for application in veins, and engineered to address the special challenges of venous lesions that are very different than those posed by arterial narrowing.”
IVOD occurs when there is impaired blood flow in the iliofemoral vein caused by acute or chronic deep-vein thrombosi (DVT), post-thrombotic syndrome, iliofemoral vein compression (including May-Thurner Syndrome), or a combination of these diseases. Symptoms include swelling of the legs, pain when standing, skin discoloration and ulcers.
The BD (Franklin Lakes, NJ, USA) Venovo venous stent is specifically designed to reopen blocked iliac and femoral veins in order to maintain adequate blood flow in symptomatic IVOD post-thrombotic and non-thrombotic lesions. The flexible nitinol stent maintains a balance of radial strength, compression resistance, and flexibility specifically designed to meet the demands of veins, as opposed to arteries. For example, the ends are flared to enhance vein-wall apposition, and broad stent sizing allows clinicians to treat large diameter veins (10-20 mm) and long lesion lengths (from 40 mm to 160 mm). Six radiopaque tantalum markers aid in positioning.
A prospective, multicenter, single-arm trial involving 170 patients showed a weighted primary patency rate of 88.3%, with a 96.9% patency rate in non-thrombotic lesions and an 81.3% patency rate in post-thrombotic lesions at 12 months, exceeding the performance goal of 74%. In addition, patients treated with the Venovo reported a significant reduction in pain symptoms and improvement in quality of life at 12 months from baseline. The Venovo venous stent was also deployed successfully to the target lesion and showed adequate coverage in all cases, and there were no fractures seen at 12 months.
“The Venovo venous stent represents a significant advance for interventionalists treating iliofemoral venous occlusive disease, an under recognized condition,” said Steve Williamson, worldwide president of peripheral intervention at BD. "We designed the Venovo venous stent in collaboration with clinicians to enable them to treat both post-thrombotic and non-thrombotic lesions. Clinicians will now have access to the broadest range of stent sizes in the United States for these difficult-to-treat lesions.”
“The unique attributes of the Venovo stent make it particularly well-suited to treat iliofemoral occlusive disease,” said Michael Dake, MD, of the University of Arizona, the principal investigator for the Venovo U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) trial. “Most importantly, it is purpose-built for application in veins, and engineered to address the special challenges of venous lesions that are very different than those posed by arterial narrowing.”
IVOD occurs when there is impaired blood flow in the iliofemoral vein caused by acute or chronic deep-vein thrombosi (DVT), post-thrombotic syndrome, iliofemoral vein compression (including May-Thurner Syndrome), or a combination of these diseases. Symptoms include swelling of the legs, pain when standing, skin discoloration and ulcers.
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery